Abstract
Significant evidence exists that Helicobacter pylori causes superficial antral gastritis, duodenitis as well as ulcer disease1, even though the bacterium rarely invades the tissue2. Inflammatory infiltrates are observed just below regions of H. pylori that are on the gastric luminal side and gastric mucosa remains intact3. The bacteria are rarely observed in non-inflamed tissue4. There is a strong correlation between the number of bacteria seen and the amount of inflammation1, and gastritis ceases after the bacteria are eradicated3.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Graham DY, Klein PD. Campylobacter pyloridis gastritis: the past, the present, and speculations about the future. Am J Gastroenterol. 1987; 82: 282–6.
Anderson LP, Holck S. Possible evidence of invasiveness of Helicobacter (Campylobacter) pylori. Eur J Clin Microbiol Infect Dis. 1990; 9: 135–8.
Rauws EAJ, Langenberg W, Houthoff HJ, Zanen HC, Tytgat GNJ. Campylobacter pyloridis associated chronic active antral gastritis: a prospective study of its prevalence and the effects of antibacterial and antiulcer treatment. Gastroenterology. 1988; 94: 44–50.
Dooley CP, Cohen H. The clinical significance of Campylobacter pylori. Ann Intern Med. 1988; 108: 70–9.
Craig PM, Territo MC, Karnes WE, Walsh JH. Helicobacter pylori secretes a chemotactic factor for monocytes and neutrophils. Gut. 1992; 33: 1020–3.
Chadwick VS, Mellor DM, Meyers DB et al. Production of peptides inducing chemotaxis and lysozomal enzyme release in human neutrophils by intestinal bacteria in vitro and in vivo. Scand J Gastroenterol. 1988; 23: 121–8.
Marasco WA, Phan SH, Krutzsch H et al. Purification and identification of formylmethionyl-leucyl-phenylalanine as the major peptide neutrophil chemotactic factor produced by Escherichia colt. J Biol Chem. 1984; 259: 5430–9.
Ferry DM, Butt TJ, Broom MF, Hunter J, Chadwick VS. Bacterial chemotactic oligopeptides and the intestinal mucosal barrier. Gastroenterology. 1989; 97: 61–7.
Magnusson KE, Dahlgren C, Sjolander A. Effect of N-formylated-methionyl-leucylphenylalanine on gut permeability. Inflammation. 1985; 9: 365–73.
Nash SJ, Stafford J, Madera JL. Effects of polymorphonuclear leukocyte transmigration on the barrier function of cultured intestinal epithelial monolayers. J Clin Invest. 1987; 80: 1104–12.
Schiffman E, Corcoran BA, Wahl SM. N-formylated peptides as chemoattractants for leukocytes. Proc Natl Acad Sci USA. 1975; 72: 1059–62.
Chang RS, Lotti VJ, Monaghan RL et al. A potent non-peptide cholecystokinin antagonist selective for peripheral tissues isolated from Aspergillus alliaceus. Science. 1985; 230: 177–9.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Anton, P.A., Reeve, J.R., Quismorio, D., Smela, K., Territo, M.C., Walsh, J.H. (1994). H. pylori supernatant contains a novel chemotactic factor for monocytes different from FMLP. In: Hunt, R.H., Tytgat, G.N.J. (eds) Helicobacter pylori. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-1418-9_16
Download citation
DOI: https://doi.org/10.1007/978-94-011-1418-9_16
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-4620-6
Online ISBN: 978-94-011-1418-9
eBook Packages: Springer Book Archive